rosiglitazone has been researched along with Leg Ulcer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ennis, WJ; Fang, MM; Koh, TJ; Mirza, RE; Novak, ML; Sui, A; Urao, N | 1 |
1 other study(ies) available for rosiglitazone and Leg Ulcer
Article | Year |
---|---|
Macrophage PPARĪ³ and impaired wound healing in type 2 diabetes.
Topics: Administration, Cutaneous; Animals; Cells, Cultured; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Humans; Interleukin-1beta; Leg Ulcer; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout; Phenotype; PPAR gamma; Prostaglandin D2; Receptors, Interleukin-1 Type I; Rosiglitazone; Skin; Thiazolidinediones; Time Factors; Wound Healing | 2015 |